Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short-term Investments (2016 - 2017)

Dexcom (DXCM) has disclosed Short-term Investments for 8 consecutive years, with $107.1 million as the latest value for Q4 2017.

  • Quarterly Short-term Investments rose 266.78% to $107.1 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $107.1 million through Dec 2017, up 266.78% year-over-year, with the annual reading at $107.1 million for FY2017, 266.78% up from the prior year.
  • Short-term Investments for Q4 2017 was $107.1 million at Dexcom, down from $123.7 million in the prior quarter.
  • The five-year high for Short-term Investments was $123.7 million in Q3 2017, with the low at $11.4 million in Q4 2013.
  • Average Short-term Investments over 5 years is $35.4 million, with a median of $28.0 million recorded in 2015.
  • The sharpest move saw Short-term Investments crashed 71.92% in 2013, then skyrocketed 317.91% in 2017.
  • Over 5 years, Short-term Investments stood at $11.4 million in 2013, then rose by 3.51% to $11.8 million in 2014, then skyrocketed by 146.61% to $29.1 million in 2015, then rose by 0.34% to $29.2 million in 2016, then skyrocketed by 266.78% to $107.1 million in 2017.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $107.1 million, $123.7 million, and $100.7 million for Q4 2017, Q3 2017, and Q2 2017 respectively.